Hokuriku designs potent, orally active, metabolically stable TxA2/CysLT1 antagonists July 22, 1998 No Comments
Long-term use of salmeterol for exercise-induced asthma results in decreased duration of action July 22, 1998 No Comments
Investigation at Kowa results in development of potent CysLT1 receptor antagonists July 7, 1998 No Comments
RSS